Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dennis Stocker

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Bioanalysis|June 16, 2016
Old to new ligand-binding assay method modificationsBruce Stouffer, Dennis Stocker
Bioanalysis|March 4, 2021
A bridging immunogenicity assay for anti-cabiralizumab antibodies: overcoming the low assay cut point and drug tolerance challengesLong Yuan, Carol R Gleason, Dennis Stocker, et al.
Bioanalysis|April 29, 2020
Strategies for method comparison when changes in the immunogenicity method are needed within a clinical programJohanna R Mora, Joleen T White, Shannon D Chilewski, et al.
The AAPS Journal|October 28, 2022
Anti-drug Antibody Sample Testing and Reporting HarmonizationDarshana Jani, Robin Marsden, Michele Gunsior, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Bioanalysis|June 16, 2016
Old to new ligand-binding assay method modificationsBruce Stouffer, Dennis Stocker
Bioanalysis|March 4, 2021
A bridging immunogenicity assay for anti-cabiralizumab antibodies: overcoming the low assay cut point and drug tolerance challengesLong Yuan, Carol R Gleason, Dennis Stocker, et al.
Bioanalysis|April 29, 2020
Strategies for method comparison when changes in the immunogenicity method are needed within a clinical programJohanna R Mora, Joleen T White, Shannon D Chilewski, et al.
The AAPS Journal|October 28, 2022
Anti-drug Antibody Sample Testing and Reporting HarmonizationDarshana Jani, Robin Marsden, Michele Gunsior, et al.
Pageof 1